Search research articles
Contact Us
Filters
Showing results (201-210 of 215) with videos related to
Page
of 22
Sort By:
Blood Advances
|
July 25, 2018
The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort
Maximilian Stahl, Michelle DeVeaux, Theo de Witte, et al.
American Journal of Hematology
|
March 30, 2026
Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex
Nancy Gillis, Christelle Colin-Leitzinger, Yi-Han Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2016
A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia
Ivana Gojo, Jan H Beumer, Keith W Pratz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 13, 2018
Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study
Maximilian Stahl, Michelle DeVeaux, Pau Montesinos, et al.
JCO Precision Oncology
|
June 17, 2026
Phase II Study of Adavosertib in Patients With Tumors Containing BRCA1 and BRCA2 Mutations: Results From the NCI-MATCH ECOG-ACRIN Cancer Research Group (EAY131) Subprotocol Z1I
Shivaani Kummar, Zihe Song, Kim A Reiss, et al.
JAMA Oncology
|
October 12, 2023
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial
Nobuyuki Takahashi, Zhonglin Hao, Liza C Villaruz, et al.
Cancer
|
October 29, 2025
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938)
Liza C Villaruz, Jingxiao Jin, Hong Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2017
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
Margaret R O'Donnell, Martin S Tallman, Camille N Abboud, et al.
Blood Reviews
|
March 18, 2023
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)
Jan Philipp Bewersdorf, Zhuoer Xie, Rafael Bejar, et al.
The New England Journal of Medicine
|
July 24, 2024
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
Mark R Litzow, Zhuoxin Sun, Ryan J Mattison, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 215) with videos related to
Sort By:
Page
of 22
Blood Advances
|
July 25, 2018
The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort
Maximilian Stahl, Michelle DeVeaux, Theo de Witte, et al.
American Journal of Hematology
|
March 30, 2026
Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex
Nancy Gillis, Christelle Colin-Leitzinger, Yi-Han Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2016
A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia
Ivana Gojo, Jan H Beumer, Keith W Pratz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 13, 2018
Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study
Maximilian Stahl, Michelle DeVeaux, Pau Montesinos, et al.
JCO Precision Oncology
|
June 17, 2026
Phase II Study of Adavosertib in Patients With Tumors Containing BRCA1 and BRCA2 Mutations: Results From the NCI-MATCH ECOG-ACRIN Cancer Research Group (EAY131) Subprotocol Z1I
Shivaani Kummar, Zihe Song, Kim A Reiss, et al.
JAMA Oncology
|
October 12, 2023
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial
Nobuyuki Takahashi, Zhonglin Hao, Liza C Villaruz, et al.
Cancer
|
October 29, 2025
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938)
Liza C Villaruz, Jingxiao Jin, Hong Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2017
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
Margaret R O'Donnell, Martin S Tallman, Camille N Abboud, et al.
Blood Reviews
|
March 18, 2023
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)
Jan Philipp Bewersdorf, Zhuoer Xie, Rafael Bejar, et al.
The New England Journal of Medicine
|
July 24, 2024
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
Mark R Litzow, Zhuoxin Sun, Ryan J Mattison, et al.
Page
of 22